ClinVar Miner

Submissions for variant NM_170665.4(ATP2A2):c.94C>T (p.Leu32Phe)

gnomAD frequency: 0.00048  dbSNP: rs141335001
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Illumina Laboratory Services, Illumina RCV000403131 SCV000376226 benign Keratosis follicularis 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
Invitae RCV002522220 SCV003259496 uncertain significance not provided 2023-02-13 criteria provided, single submitter clinical testing In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ATP2A2 protein function. ClinVar contains an entry for this variant (Variation ID: 307160). This missense change has been observed in individual(s) with Darier disease (PMID: 21519848, 23356892, 30345710). This variant is present in population databases (rs141335001, gnomAD 0.05%), and has an allele count higher than expected for a pathogenic variant. This sequence change replaces leucine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 32 of the ATP2A2 protein (p.Leu32Phe).
Molecular Genetics, Royal Melbourne Hospital RCV000403131 SCV004812607 uncertain significance Keratosis follicularis 2023-06-06 criteria provided, single submitter clinical testing This sequence change in ATP2A2 is predicted to replace leucine with phenylalanine at codon 32, p.(Leu32Phe). The leucine residue is moderately conserved (100 vertebrates, UCSC), and is located in the cation ATPase N domain. There is a small physicochemical difference between leucine and phenylalanine. The highest population minor allele frequency in the population database gnomAD v2.1 is 0.05% (53/107,582 alleles) in the European (non-Finnish) population. This variant has been reported in at least one individual with a diagnosis of Darier's disease (PMID: 23356892). Computational evidence predicts a benign effect for the missense substitution (REVEL = 0.213). Based on the classification scheme RMH Modified ACMG/AMP Guidelines v1.6.1, this variant is classified as a VARIANT OF UNCERTAIN SIGNIFICANCE. Following criteria are met: BP4.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.